Silver sponsor

BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company develops innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care

Fisabio

FISABIO Sequencing Service provides complete NGS solutions to our customers beginning with a free consultation with our experienced scientists regarding project design and initiation. We offer both standard and custom solutions for NGS library preparation, sequencing, and bioinformatics analysis support. Our experienced team is available to advise and help with your project at every step. We provide you with NGS services and capacities based on the market leading technologies:

  • Illumina Miseq
  • Illumine NextSeq500
  • MinION oxford nanopore
  • Sequel PacBIO (Soon, end of 2019)

We are involved since 2014 in several Mycobaterium sequencing (Whole genome sequencing and RNA-seq) and bioinformatics analysis projects:

  • Swiss tropical and public health institute
  • Universidade do Minho
  • Universidad de Zaragoza
  • IBV-CSIC (Biomedicine Institute of Valencia)
  • Universidad de Valencia
  • (ITM) The Institute of Tropical Medicine, Belgium
  • National Centre for TB and Lung Diseases of Georgia
  • Pasteur Institute (Paris)
  • GSK Global Health R&D Tuberculosis Unit

Bronze sponsor

Biomérieux

bioMérieux develops and produces in vitro diagnostic solutions (systems, reagents and software) for private and hospital laboratories, mainly for the diagnosis of infectious diseases. The results obtained from a patient sample (blood, urine, stool, cerebrospinal fluid, saliva, etc.) provide doctors with information to support their decisions.  For 25 years, bioMérieux has also applied the expertise acquired in the clinical sector to meeting industrial microbiology needs, making it possible to manage contamination risks in agri-food, pharmaceutical and cosmetic products, at each step of the production chain.

Oxford Nanopore

Oxford Nanopore Technologies has developed the world's first nanopore DNA and RNA sequencing devices. The MinION is a portable, real-time, long-read, low-cost device designed to bring easy biological analyses to anyone, whether in scientific research, education or real world applications such as disease/pathogen surveillance, environmental monitoring, food chain surveillance, self-quantification or microgravity biology. The GridION and PromethION devices serve users with larger projects or more samples. Oxford Nanopore Technologies products are currently for Research Use Only